EUVIMEDEUVIMED entdecken
Crossref

Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization

Sicheng Liu, Fei Peng, Jing Liu, Weiwei Wu, Liu He, Hangxue Cao, Congyan Liu, Feng Qiu iD, Wensheng Zhang

Small · 2025-09 · 21 (36)

DOI: 10.1002/smll.202505459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 20.07.2025. Verfasst von Sicheng Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Peptides, Protein Aggregates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Chengdu Municipal Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid‐β fibrillization, characterized by ordered and compact peptide assembly, is a hallmark and a key therapeutic target of Alzheimer's disease. However, it is still challenging to completely inhibit or even reverse the fibrillization process. Here, it is reported an anti‐fibrillization mechanism mediated by short peptides with a novel soft‐aggregation behavior. Unlike classical peptide self‐assembly forming ordered nanostructures, several peptides derived from an analgesic peptide underwent dynamic self‐aggregation into irregular and loose nanoparticles, which is driven by strong hydrophobic interaction but not by strong hydrogen bonds. By systematically comparing different peptides, it is confirmed a direct correlation between the soft‐aggregation behavior and the anti‐fibrillization efficacy. It is further demonstrated that Ana‐5F, one of these peptides with a superior anti‐fibrillization ability, could bind with two core hydrophobic fragments in amyloid‐β and effectively inhibit their fibrillization. Consequently, Ana‐5F effectively inhibited and reversed fibrillization of full‐length amyloid‐β. In rat models, Ana‐5F cleaned up mature amyloid‐β fibrils and protected the animals from cognitive impairment and anxiety‐like behaviors. This study, for the first time, defined soft‐aggregation as a novel peptide aggregation behavior distinct from classical ordered peptide self‐assembly. It also provided a strategic approach to curing Alzheimer's disease by utilizing the soft‐aggregation mechanism to eliminate pathological amyloid‐β fibrils.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesPeptidesProtein AggregatesAnimalsRatsHydrophobic and Hydrophilic InteractionsMaleNanoparticles

Stichwörter der Autor:innen

alzheimer's diseaseamyloid beta‐peptidesanti‐fibrillizationhydrogen bondsself‐assembly

Substanzen

Amyloid beta-PeptidesPeptidesProtein Aggregates

Autor:innen und Institutionen

  • Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China.

ORCID-Profile: Feng Qiu

Förderung

  • Chengdu Municipal Science and Technology Program

Zitieren

APA

Liu, S., Peng, F., Liu, J., Wu, W., He, L., Cao, H., Liu, C., Qiu, F., & Zhang, W. (2025). Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization. Small, 21(36). https://doi.org/10.1002/smll.202505459

Vancouver

Liu S, Peng F, Liu J, Wu W, He L, Cao H, et al. Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization. Small. 2025;21(36). doi:10.1002/smll.202505459

BibTeX
@article{Liu2025,
  author = {Liu, Sicheng and Peng, Fei and Liu, Jing and Wu, Weiwei and He, Liu and Cao, Hangxue and Liu, Congyan and Qiu, Feng and Zhang, Wensheng},
  title = {Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {36},
  doi = {10.1002/smll.202505459}
}
Kostenlos starten →